首页> Cardiovascular drugs and therapy> An Exploratory Study of Dapagliflozin for the Attenuation of Albuminuria in Patients with Heart Failure and Type 2 Diabetes Mellitus (DAPPER).

An Exploratory Study of Dapagliflozin for the Attenuation of Albuminuria in Patients with Heart Failure and Type 2 Diabetes Mellitus (DAPPER).

导出原文传递

翻译打印收藏纠错

第一作者： Fumiki,Yoshihara

第一单位： Division of Hypertension and Nephrology, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.

作者： Fumiki,Yoshihara ^[1] ; Miki,Imazu ^[2] ; Toshimitsu,Hamasaki ^[3] ; Toshihisa,Anzai ^[4] ; Satoshi,Yasuda ^[4] ; Shin,Ito ^[5] ; Haruko,Yamamoto ^[3] ; Kazuhiko,Hashimura ^[6] ; Yoshio,Yasumura ^[7] ; Kiyoshi,Mori ^[8] ; Masataka,Watanabe ^[9] ; Masanori,Asakura ^[10] ; Masafumi,Kitakaze ^[11] ; DAPPER investigators and study coordinators

作者单位： Division of Hypertension and Nephrology, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan. ^[1] Department of Clinical Medicine and Development, National Cerebral and Cardiovascular Center, Suita, Osaka, 565-8565, Japan.;Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan. ^[2] Department of Advance Medical Technology Development, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan. ^[3] Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan. ^[4] Department of Clinical Medicine and Development, National Cerebral and Cardiovascular Center, Suita, Osaka, 565-8565, Japan. ^[5] Department of Cardiovascular Medicine, Hanwa Memorial Hospital, Osaka, Japan. ^[6] Cardiac Center, Osaka Police Hospital, Osaka, Japan. ^[7] Department of Nephrology and Kidney Research, Shizuoka General Hospital, Shizuoka, Japan. ^[8] Department Cardiology, Tokyo Medical University, Tokyo, Japan. ^[9] Department of Internal Medicine, Cardiovascular Division, Hyogo College of Medicine, Nishinomiya, Hyogo, Japan. ^[10] Department of Clinical Medicine and Development, National Cerebral and Cardiovascular Center, Suita, Osaka, 565-8565, Japan. kitakaze@zf6.so-net.ne.jp.;Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan. kitakaze@zf6.so-net.ne.jp. ^[11]

关键词 Cardiovascular protection Chronic heart failure Dapagliflozin Type 2 diabetes mellitus Urinary albumin-to-creatinine ratio